Prilenia is a clinical-stage biotech company that develops novel treatments for neurodegenerative and neurodevelopmental disorders. Its lead asset is Pridopidine, a n oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children. The company was founded in 2018 and is based in Israel, the Netherlands, and Boston.

Herzliya, Israel

Boston, MA, USA

Prilenia

Amplitude Ventures Inc.

Amplitude Ventures

Discover opportunities across our network of transformational companies

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Amplitudevc Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Amplitudevc network as they come up.

You can always update this information later.

Welcome to the Amplitudevc talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Amplitudevc company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Portfolio Careers